With a valid prescription, patients can access the starting dose of Zepbound single-dose vial (2.5 mg) for as low as $299 per ...

Under the partnership, Lilly will pay IU up to $40 million to build clinical trial infrastructure, accelerate access to ...

The steep monthly costs of GLP-1 medications have long been a major obstacle for many patients trying to find effective ...

The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand ...

Eli Lilly will cut prices for its weight loss drug Zepbound, with single-dose vials now available for $299 per month through ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

The Zepbound price cut is the latest move in a price war with Denmark’s Novo Nordisk, which is making it significantly less ...

Indiana University and Eli Lilly are working together to expand clinical trials in the state. IU President Pamela Whitten and ...

Eli Lilly & Company (NYSE:LLY) ranks among the Best Low Volatility Investments in December 2025. Eli Lilly & Company ...

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for weight management. | Drugmaker Eli Lilly is rolling out a new model to make it ...

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's LillyDirect website.

The founder of the USC Annenberg Inclusion Initiative was recognized for her tireless work in equality and inclusion in ...